FICKENSCHER JAMES E (Chief Financial Officer) sold 2.3% of their position (9K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $11.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/14/2023ACC: 0001062993-23-018020
Officer· Chief Financial Officer
Since Aug 2018
+22.20K
Net shares
Net buyer
$11.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
31.20K acquired · 9K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+31.20K
Price / share
—
Trade value
—
% of position
8.8%
9/12/2023
355.88K→387.08K
Common Stock
Direct
Shares
−9K
Price / share
$1.33
Trade value
$11.93K
% of position
2.3%
9/13/2023
387.08K→378.09K
Total
Net shares
+22.20K
Net value
-$11.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2023 | A · Award | +31.20K | — | — | 8.8% | 355.88K | 387.08K |
| Common Stock Direct | 9/13/2023 | S · Sale | −9K | $1.33 | $11.93K | 2.3% | 387.08K | 378.09K |
| Total | +22.20K | -$11.93K | ||||||
Derivative Transactions0
No derivative transactions reported